PURA VIDA INVESTMENTS, LLC - Q3 2019 holdings

Add to watchlist

$585 Million is the total value of PURA VIDA INVESTMENTS, LLC's 90 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 95.9% .

All

			Value		Shares		↓ Weighting
XLV	New	SELECT SECTOR SPDR TRput	$22,533,000	–	250,000	+100.0%	3.85%	–
INSP	Sell	INSPIRE MED SYS INC	$21,827,000	-10.0%	357,700	-10.6%	3.73%	+1.2%
AMGN	New	AMGEN INCcall	$19,351,000	–	100,000	+100.0%	3.31%	–
IWM	Sell	ISHARES TRput	$18,918,000	-44.7%	125,000	-43.2%	3.23%	-37.8%
NSTG	Buy	NANOSTRING TECHNOLOGIES INC	$18,865,000	-13.8%	873,800	+21.2%	3.22%	-3.0%
FXH	Buy	FIRST TR EXCHANGE TRADED FDput	$18,505,000	+19.5%	250,000	+25.0%	3.16%	+34.4%
INSP	Buy	INSPIRE MED SYS INCcall	$16,781,000	+176.7%	275,000	+175.0%	2.87%	+211.3%
ZBH	Sell	ZIMMER BIOMET HLDGS INC	$16,121,000	-14.4%	117,442	-26.6%	2.75%	-3.7%
NSTG	Buy	NANOSTRING TECHNOLOGIES INCcall	$15,329,000	+106.1%	710,000	+189.8%	2.62%	+132.0%
ICUI	Buy	ICU MED INC	$14,763,000	-25.9%	92,500	+16.9%	2.52%	-16.7%
MJ	Buy	ETF MANAGERS TRput	$14,532,000	+7.9%	700,000	+64.7%	2.48%	+21.4%
ESTA	Buy	ESTABLISHMENT LABS HLDGS INC	$14,091,000	+30.9%	745,163	+52.2%	2.41%	+47.2%
REGN	New	REGENERON PHARMACEUTICALScall	$13,870,000	–	50,000	+100.0%	2.37%	–
ZBH	New	ZIMMER BIOMET HLDGS INCcall	$13,727,000	–	100,000	+100.0%	2.34%	–
XENT	Buy	INTERSECT ENT INCcall	$13,183,000	+189.6%	775,000	+287.5%	2.25%	+225.9%
STAA	Sell	STAAR SURGICAL CO	$12,993,000	-17.9%	504,012	-6.4%	2.22%	-7.6%
SNN	Buy	SMITH & NEPHEW GROUP PLCcall	$12,754,000	+95.3%	265,000	+76.7%	2.18%	+119.7%
BHVN		BIOHAVEN PHARMACTL HLDG CO Lcall	$12,516,000	-4.7%	300,000	0.0%	2.14%	+7.2%
XBI	New	SPDR SER TRput	$11,438,000	–	150,000	+100.0%	1.95%	–
XENT	Buy	INTERSECT ENT INC	$11,397,000	+61.1%	670,000	+115.6%	1.95%	+81.3%
AGN	Buy	ALLERGAN PLC	$11,294,000	+43.2%	67,109	+42.5%	1.93%	+61.0%
WAT	New	WATERS CORPcall	$11,162,000	–	50,000	+100.0%	1.91%	–
REGN	Buy	REGENERON PHARMACEUTICALS	$11,096,000	+77.3%	40,000	+100.0%	1.90%	+99.3%
IBB	New	ISHARES TRcall	$10,865,000	–	109,200	+100.0%	1.86%	–
GRFS	New	GRIFOLS S Asp adr rep b nvt	$9,944,000	–	496,201	+100.0%	1.70%	–
GILD	Buy	GILEAD SCIENCES INC	$9,507,000	+40.7%	150,000	+50.0%	1.62%	+58.3%
ILMN	New	ILLUMINA INCcall	$9,127,000	–	30,000	+100.0%	1.56%	–
SNN	Sell	SMITH & NEPHEW GROUP PLCspdn adr new	$8,663,000	-20.4%	180,000	-28.0%	1.48%	-10.5%
CHRS	New	COHERUS BIOSCIENCES INCcall	$8,104,000	–	400,000	+100.0%	1.38%	–
SRPT	New	SAREPTA THERAPEUTICS INCput	$7,532,000	–	100,000	+100.0%	1.29%	–
RCM	Buy	R1 RCM INC	$6,761,000	-17.0%	757,139	+17.0%	1.16%	-6.6%
DXCM	Sell	DEXCOM INC	$6,716,000	-28.0%	45,000	-27.8%	1.15%	-19.1%
VRAY	Buy	VIEWRAY INCcall	$6,525,000	+640.6%	2,250,000	+2150.0%	1.12%	+732.1%
UNH		UNITEDHEALTH GROUP INCput	$6,520,000	-10.9%	30,000	0.0%	1.11%	+0.2%
CGC	New	CANOPY GROWTH CORPput	$6,306,000	–	275,000	+100.0%	1.08%	–
IVC	Sell	INVACARE CORP	$6,149,000	+27.4%	819,874	-11.8%	1.05%	+43.2%
KIDS	Buy	ORTHOPEDIATRICS CORP	$6,082,000	+8.0%	172,500	+19.5%	1.04%	+21.5%
STAA	Buy	STAAR SURGICAL COcall	$5,960,000	-1.6%	231,200	+12.1%	1.02%	+10.7%
BAX	Buy	BAXTER INTL INC	$5,248,000	+70.9%	60,000	+60.0%	0.90%	+92.3%
ALXN	New	ALEXION PHARMACEUTICALS INC	$5,142,000	–	52,500	+100.0%	0.88%	–
MDCO	New	MEDICINES COcall	$5,000,000	–	100,000	+100.0%	0.85%	–
INOV	New	INOVALON HLDGS INCcall	$4,917,000	–	300,000	+100.0%	0.84%	–
CNMD	Sell	CONMED CORP	$4,567,000	+6.7%	47,500	-5.0%	0.78%	+20.0%
TXG	New	10X GENOMICS INC	$4,536,000	–	90,000	+100.0%	0.78%	–
QTNT	Buy	QUOTIENT LTD	$4,391,000	+114.7%	565,094	+158.4%	0.75%	+141.2%
ICUI	Sell	ICU MED INCcall	$4,389,000	-56.4%	27,500	-31.2%	0.75%	-51.0%
SPPI		SPECTRUM PHARMACEUTICALS INCput	$4,148,000	-3.6%	500,000	0.0%	0.71%	+8.4%
GNLN	Buy	GREENLANE HLDGS INCcl a	$4,129,000	-7.4%	1,217,890	+161.9%	0.70%	+4.1%
MRTX	New	MIRATI THERAPEUTICS INCcall	$3,896,000	–	50,000	+100.0%	0.67%	–
GWPH	New	GW PHARMACEUTICALS PLCads	$3,451,000	–	30,000	+100.0%	0.59%	–
RCM	New	R1 RCM INCcall	$3,126,000	–	350,000	+100.0%	0.53%	–
UTHR		UNITED THERAPEUTICS CORP DEL	$3,110,000	+2.2%	39,000	0.0%	0.53%	+14.9%
WMGI	New	WRIGHT MED GROUP N Vcall	$3,095,000	–	150,000	+100.0%	0.53%	–
IVC	New	INVACARE CORPcall	$3,000,000	–	400,000	+100.0%	0.51%	–
MASI	Sell	MASIMO CORP	$2,991,000	-46.4%	20,099	-46.4%	0.51%	-39.7%
APYX	Buy	APYX MEDICAL CORPORATION	$2,883,000	+8.0%	425,872	+7.2%	0.49%	+21.5%
SUPN	New	SUPERNUS PHARMACEUTICALS INCput	$2,748,000	–	100,000	+100.0%	0.47%	–
BYND	New	BEYOND MEAT INCput	$2,601,000	–	17,500	+100.0%	0.44%	–
CSTL	New	CASTLE BIOSCIENCES INC	$2,383,000	–	131,718	+100.0%	0.41%	–
OTIC		OTONOMY INC	$2,374,000	-13.1%	993,463	0.0%	0.41%	-2.2%
TNDM	Buy	TANDEM DIABETES CARE INC	$2,359,000	+265.7%	40,000	+300.0%	0.40%	+311.2%
FLDM	Buy	FLUIDIGM CORP DEL	$2,315,000	-21.7%	500,000	+108.3%	0.40%	-12.0%
BDSI	Sell	BIODELIVERY SCIENCES INTL IN	$2,169,000	-25.4%	515,111	-17.6%	0.37%	-15.9%
CYTK	New	CYTOKINETICS INC	$2,141,000	–	188,096	+100.0%	0.37%	–
VRAY	Sell	VIEWRAY INC	$2,131,000	-71.5%	734,994	-13.5%	0.36%	-68.0%
ACHN	New	ACHILLION PHARMACEUTICALS IN	$2,040,000	–	566,600	+100.0%	0.35%	–
TGTX		TG THERAPEUTICS INC	$1,992,000	-35.1%	354,719	0.0%	0.34%	-27.0%
MSON	Buy	MISONIX INC	$1,882,000	-20.4%	93,645	+0.6%	0.32%	-10.6%
CMD	New	CANTEL MED CORPput	$1,870,000	–	25,000	+100.0%	0.32%	–
BHVN	New	BIOHAVEN PHARMACTL HLDG CO L	$1,669,000	–	40,000	+100.0%	0.28%	–
NVAX		NOVAVAX INCcall	$1,646,000	-14.3%	327,800	0.0%	0.28%	-3.8%
CBAY	New	CYMABAY THERAPEUTICS INCcall	$1,536,000	–	300,000	+100.0%	0.26%	–
SAGE	New	SAGE THERAPEUTICS INCcall	$1,403,000	–	10,000	+100.0%	0.24%	–
DCPH	New	DECIPHERA PHARMACEUTICALS IN	$1,392,000	–	41,000	+100.0%	0.24%	–
FLDM	New	FLUIDIGM CORP DELcall	$1,389,000	–	300,000	+100.0%	0.24%	–
STML	Sell	STEMLINE THERAPEUTICS INC	$1,379,000	-41.4%	132,422	-13.8%	0.24%	-33.9%
ARVN	New	ARVINAS INC	$1,384,000	–	64,209	+100.0%	0.24%	–
KALA	Buy	KALA PHARMACEUTICALS INC	$1,266,000	-33.5%	332,831	+11.5%	0.22%	-25.3%
ZYME	New	ZYMEWORKS INC	$1,240,000	–	50,000	+100.0%	0.21%	–
INOV	New	INOVALON HLDGS INC	$1,229,000	–	75,000	+100.0%	0.21%	–
AXSM	Buy	AXSOME THERAPEUTICS INC	$1,184,000	+489.1%	58,519	+650.2%	0.20%	+551.6%
CHRS	Sell	COHERUS BIOSCIENCES INC	$1,013,000	-58.0%	50,000	-54.2%	0.17%	-52.7%
NTRA	New	NATERA INC	$984,000	–	30,000	+100.0%	0.17%	–
ITCI	New	INTRA CELLULAR THERAPIES INC	$815,000	–	109,130	+100.0%	0.14%	–
ARDX	New	ARDELYX INC	$658,000	–	140,085	+100.0%	0.11%	–
ENDP	New	ENDO INTL PLCcall	$642,000	–	200,000	+100.0%	0.11%	–
QURE	New	UNIQURE NV	$590,000	–	15,000	+100.0%	0.10%	–
ADVM	New	ADVERUM BIOTECHNOLOGIES INC	$545,000	–	100,000	+100.0%	0.09%	–
AVDL	New	AVADEL PHARMACEUTICALS PLCsponsored adr	$505,000	–	121,435	+100.0%	0.09%	–
ALRN	New	AILERON THERAPEUTICS INC	$91,000	–	135,548	+100.0%	0.02%	–
SYNH	Exit	SYNEOS HEALTH INCcl a	$0	–	-5,000	-100.0%	-0.04%	–
VTGN	Exit	VISTAGEN THERAPEUTICS INC	$0	–	-425,000	-100.0%	-0.05%	–
ACST	Exit	ACASTI PHARMA INCcl a new	$0	–	-333,099	-100.0%	-0.06%	–
	Exit	APTOSE BIOSCIENCES INC	$0	–	-150,000	-100.0%	-0.06%	–
AMRS	Exit	AMYRIS INC	$0	–	-247,668	-100.0%	-0.13%	–
QTNT	Exit	QUOTIENT LTDcall	$0	–	-112,500	-100.0%	-0.16%	–
IART	Exit	INTEGRA LIFESCIENCES HLDGS C	$0	–	-25,000	-100.0%	-0.21%	–
ADPT	Exit	ADAPTIVE BIOTECHNOLOGIES COR	$0	–	-35,000	-100.0%	-0.26%	–
PSNL	Exit	PERSONALIS INC	$0	–	-65,000	-100.0%	-0.27%	–
CRY	Exit	CRYOLIFE INC	$0	–	-70,000	-100.0%	-0.32%	–
LIVN	Exit	LIVANOVA PLC	$0	–	-30,000	-100.0%	-0.33%	–
GKOS	Exit	GLAUKOS CORP	$0	–	-30,000	-100.0%	-0.34%	–
INCY	Exit	INCYTE CORP	$0	–	-28,318	-100.0%	-0.36%	–
BEAT	Exit	BIOTELEMETRY INCput	$0	–	-50,000	-100.0%	-0.37%	–
SILK	Exit	SILK RD MED INC	$0	–	-50,000	-100.0%	-0.37%	–
AXNX	Exit	AXONICS MODULATION TECHNOLOG	$0	–	-65,000	-100.0%	-0.40%	–
CNCE	Exit	CONCERT PHARMACEUTICALS INCcall	$0	–	-224,900	-100.0%	-0.41%	–
LIVN	Exit	LIVANOVA PLCput	$0	–	-40,000	-100.0%	-0.44%	–
ARAY	Exit	ACCURAY INCcall	$0	–	-800,000	-100.0%	-0.47%	–
VAPO	Exit	VAPOTHERM INC	$0	–	-140,000	-100.0%	-0.49%	–
INGN	Exit	INOGEN INCcall	$0	–	-50,000	-100.0%	-0.51%	–
WMGI	Exit	WRIGHT MED GROUP N V	$0	–	-122,500	-100.0%	-0.56%	–
BRKS	Exit	BROOKS AUTOMATION INC NEW	$0	–	-95,000	-100.0%	-0.56%	–
AVNS	Exit	AVANOS MED INC	$0	–	-85,000	-100.0%	-0.56%	–
ITCI	Exit	INTRA CELLULAR THERAPIES INCcall	$0	–	-300,000	-100.0%	-0.59%	–
AXGN	Exit	AXOGEN INCput	$0	–	-200,000	-100.0%	-0.60%	–
OMCL	Exit	OMNICELL COMput	$0	–	-50,000	-100.0%	-0.65%	–
CTLT	Exit	CATALENT INC	$0	–	-80,000	-100.0%	-0.66%	–
AMRN	Exit	AMARIN CORP PLCspons adr new	$0	–	-235,204	-100.0%	-0.69%	–
AVTR	Exit	AVANTOR INC	$0	–	-250,000	-100.0%	-0.72%	–
GKOS	Exit	GLAUKOS CORPcall	$0	–	-65,000	-100.0%	-0.74%	–
OFIX	Exit	ORTHOFIX MED INC	$0	–	-93,794	-100.0%	-0.75%	–
BRKR	Exit	BRUKER CORP	$0	–	-100,000	-100.0%	-0.76%	–
MYGN	Exit	MYRIAD GENETICS INCcall	$0	–	-200,000	-100.0%	-0.84%	–
ABBV	Exit	ABBVIE INC	$0	–	-79,980	-100.0%	-0.88%	–
PPH	Exit	VANECK VECTORS ETF TRput	$0	–	-100,000	-100.0%	-0.89%	–
MMSI	Exit	MERIT MED SYS INCput	$0	–	-100,000	-100.0%	-0.90%	–
GH	Exit	GUARDANT HEALTH INC	$0	–	-70,000	-100.0%	-0.92%	–
ARQL	Exit	ARQULE INC	$0	–	-633,789	-100.0%	-1.06%	–
DHR	Exit	DANAHER CORPORATION	$0	–	-50,000	-100.0%	-1.08%	–
ABMD	Exit	ABIOMED INCput	$0	–	-30,000	-100.0%	-1.19%	–
IRTC	Exit	IRHYTHM TECHNOLOGIES INCput	$0	–	-100,000	-100.0%	-1.20%	–
GMED	Exit	GLOBUS MED INCput	$0	–	-200,000	-100.0%	-1.28%	–
INCY	Exit	INCYTE CORPcall	$0	–	-100,000	-100.0%	-1.29%	–
BSX	Exit	BOSTON SCIENTIFIC CORP	$0	–	-235,000	-100.0%	-1.53%	–
ARQL	Exit	ARQULE INCcall	$0	–	-1,063,700	-100.0%	-1.78%	–
GH	Exit	GUARDANT HEALTH INCput	$0	–	-142,200	-100.0%	-1.86%	–
SYK	Exit	STRYKER CORPORATIONcall	$0	–	-60,000	-100.0%	-1.87%	–
BDX	Exit	BECTON DICKINSON & COcall	$0	–	-50,000	-100.0%	-1.91%	–
IHI	Exit	ISHARES TRput	$0	–	-100,000	-100.0%	-3.66%	–
SPY	Exit	SPDR S&P 500 ETF TRput	$0	–	-150,000	-100.0%	-6.67%	–

Original filings

The following EDGAR filing(s) were analyzed to create this report:

View 13F-HR/A filed 2021-02-12

Signatures

The EDGAR filing(s) were signed by:

Alyssa Romano — Chief Compliance Officer and Chief Financial Officer

Top long-term holdings

Name	Quarters owned	Latest quarter owned	Max weighting
ICU MED INC	26	Q2 2023	4.2%
NANOSTRING TECHNOLOGIES INC	26	Q2 2023	3.3%
VIEWRAY INC	25	Q2 2023	3.2%
LIVANOVA PLC	23	Q3 2023	3.8%
ALEXION PHARMACEUTICALS INC	23	Q1 2021	4.3%
INSPIRE MED SYS INC	22	Q3 2023	3.7%
BOSTON SCIENTIFIC CORP	22	Q3 2022	4.8%
INVACARE CORP	22	Q3 2021	2.8%
ESTABLISHMENT LABS HLDGS INC	21	Q3 2023	5.0%
INTERSECT ENT INC	21	Q2 2021	2.6%

View PURA VIDA INVESTMENTS, LLC's complete holdings history.

Latest significant ownerships (13-D/G)

PURA VIDA INVESTMENTS, LLC Q3 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
	Filed	Shares	Percentage
Stryve Foods Holdings, LLC	April 19, 2023	1,470,649	5.6%
ICAD INC	March 15, 2023	1,277,214	5.0%
ESTABLISHMENT LABS HOLDINGS INC.	February 14, 2023	1,002,767	4.1%
Pulmonx Corp	February 14, 2023	1,216,258	3.2%
Quotient Ltd^{Sold out}	February 14, 2023	0	0.0%
Universe Pharmaceuticals INC^{Sold out}	February 14, 2023	0	0.0%
MedMen Enterprises, Inc.	April 29, 2022	139,755,072	21.4%
INVACARE CORP^{Sold out}	February 14, 2022	0	0.0%
MedAvail Holdings, Inc.	February 14, 2022	714,120	2.2%
TELA Bio, Inc.	February 14, 2022	564,120	3.9%

View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.

Latest filings

Type	Filed
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
13F-HR	2024-02-13
SC 13D/A	2023-12-29

View PURA VIDA INVESTMENTS, LLC's complete filings history.

All filings

View complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

The reported total value is incorrect (585386000.0 != 585391000.0)
The reported has been restated
The reported has been amended

Export PURA VIDA INVESTMENTS, LLC's holdings